nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—NR1I2—Docetaxel—melanoma	0.303	0.57	CbGbCtD
Ethinyl Estradiol—ABCB1—melanoma	0.208	1	CbGaD
Ethinyl Estradiol—CYP3A4—Temozolomide—melanoma	0.0632	0.119	CbGbCtD
Ethinyl Estradiol—ABCC2—Docetaxel—melanoma	0.0609	0.114	CbGbCtD
Ethinyl Estradiol—ABCB1—Dactinomycin—melanoma	0.0384	0.0722	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vemurafenib—melanoma	0.0346	0.0651	CbGbCtD
Ethinyl Estradiol—ABCB1—Docetaxel—melanoma	0.0198	0.0373	CbGbCtD
Ethinyl Estradiol—CYP3A4—Docetaxel—melanoma	0.0119	0.0223	CbGbCtD
Ethinyl Estradiol—Erythema nodosum—Vemurafenib—melanoma	0.00461	0.0346	CcSEcCtD
Ethinyl Estradiol—Cerebral infarction—Carmustine—melanoma	0.00324	0.0243	CcSEcCtD
Ethinyl Estradiol—Estramustine—MAP2—melanoma	0.00284	0.504	CrCbGaD
Ethinyl Estradiol—Thromboembolic event—Docetaxel—melanoma	0.00252	0.0189	CcSEcCtD
Ethinyl Estradiol—Local reaction—Bleomycin—melanoma	0.00218	0.0164	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Vemurafenib—melanoma	0.0018	0.0135	CcSEcCtD
Ethinyl Estradiol—Embolism—Temozolomide—melanoma	0.00159	0.0119	CcSEcCtD
Ethinyl Estradiol—Thrombosis—Carmustine—melanoma	0.00149	0.0112	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Vemurafenib—melanoma	0.00145	0.0109	CcSEcCtD
Ethinyl Estradiol—Influenza-like symptoms—Temozolomide—melanoma	0.00143	0.0107	CcSEcCtD
Ethinyl Estradiol—Menorrhagia—Temozolomide—melanoma	0.00138	0.0103	CcSEcCtD
Ethinyl Estradiol—Cystitis noninfective—Bleomycin—melanoma	0.00118	0.00887	CcSEcCtD
Ethinyl Estradiol—Breast pain—Temozolomide—melanoma	0.00117	0.00878	CcSEcCtD
Ethinyl Estradiol—Cystitis—Bleomycin—melanoma	0.00117	0.00877	CcSEcCtD
Ethinyl Estradiol—Amenorrhoea—Temozolomide—melanoma	0.00116	0.00872	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Vemurafenib—melanoma	0.00113	0.00851	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Vemurafenib—melanoma	0.00112	0.00838	CcSEcCtD
Ethinyl Estradiol—Infestation—Vemurafenib—melanoma	0.00112	0.00838	CcSEcCtD
Ethinyl Estradiol—Herpes simplex—Temozolomide—melanoma	0.00111	0.00831	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Vemurafenib—melanoma	0.00109	0.00822	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Bleomycin—melanoma	0.00109	0.00821	CcSEcCtD
Ethinyl Estradiol—Embolism—Docetaxel—melanoma	0.00106	0.00793	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Temozolomide—melanoma	0.00102	0.00766	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Temozolomide—melanoma	0.00099	0.00744	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Vemurafenib—melanoma	0.000984	0.0074	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Temozolomide—melanoma	0.000962	0.00723	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Carmustine—melanoma	0.000954	0.00717	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Vemurafenib—melanoma	0.000947	0.00712	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Vemurafenib—melanoma	0.000936	0.00703	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Temozolomide—melanoma	0.000922	0.00692	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Vemurafenib—melanoma	0.000909	0.00683	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Bleomycin—melanoma	0.000895	0.00673	CcSEcCtD
Ethinyl Estradiol—Alopecia—Vemurafenib—melanoma	0.000885	0.00665	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Vemurafenib—melanoma	0.000872	0.00655	CcSEcCtD
Ethinyl Estradiol—Back pain—Vemurafenib—melanoma	0.000843	0.00634	CcSEcCtD
Ethinyl Estradiol—Hot flush—Temozolomide—melanoma	0.000791	0.00594	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Temozolomide—melanoma	0.000784	0.00589	CcSEcCtD
Ethinyl Estradiol—Amenorrhoea—Docetaxel—melanoma	0.000771	0.0058	CcSEcCtD
Ethinyl Estradiol—Cough—Vemurafenib—melanoma	0.000761	0.00572	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000737	0.00554	CcSEcCtD
Ethinyl Estradiol—Affect lability—Temozolomide—melanoma	0.000728	0.00547	CcSEcCtD
Ethinyl Estradiol—Infection—Vemurafenib—melanoma	0.000707	0.00531	CcSEcCtD
Ethinyl Estradiol—Mood swings—Temozolomide—melanoma	0.000701	0.00527	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Vemurafenib—melanoma	0.000698	0.00524	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Vemurafenib—melanoma	0.000691	0.00519	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Bleomycin—melanoma	0.000686	0.00515	CcSEcCtD
Ethinyl Estradiol—Blood pressure increased—Docetaxel—melanoma	0.000678	0.00509	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Temozolomide—melanoma	0.000669	0.00502	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Bleomycin—melanoma	0.000666	0.00501	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Bleomycin—melanoma	0.000663	0.00498	CcSEcCtD
Ethinyl Estradiol—Influenza like illness—Docetaxel—melanoma	0.000658	0.00495	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Temozolomide—melanoma	0.000644	0.00484	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Docetaxel—melanoma	0.000644	0.00484	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Temozolomide—melanoma	0.000615	0.00462	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Vemurafenib—melanoma	0.000614	0.00462	CcSEcCtD
Ethinyl Estradiol—Fatigue—Vemurafenib—melanoma	0.000613	0.00461	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Docetaxel—melanoma	0.000613	0.0046	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Bleomycin—melanoma	0.00061	0.00458	CcSEcCtD
Ethinyl Estradiol—Constipation—Vemurafenib—melanoma	0.000608	0.00457	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Bleomycin—melanoma	0.000607	0.00456	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Bleomycin—melanoma	0.000604	0.00454	CcSEcCtD
Ethinyl Estradiol—Dysuria—Temozolomide—melanoma	0.000598	0.00449	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Temozolomide—melanoma	0.000594	0.00447	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Temozolomide—melanoma	0.000591	0.00444	CcSEcCtD
Ethinyl Estradiol—Depression—Carmustine—melanoma	0.000588	0.00442	CcSEcCtD
Ethinyl Estradiol—Weight increased—Temozolomide—melanoma	0.000582	0.00437	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Temozolomide—melanoma	0.000579	0.00435	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Carmustine—melanoma	0.000578	0.00435	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Carmustine—melanoma	0.000574	0.00431	CcSEcCtD
Ethinyl Estradiol—Infestation—Temozolomide—melanoma	0.00057	0.00428	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Temozolomide—melanoma	0.00057	0.00428	CcSEcCtD
Ethinyl Estradiol—Depression—Temozolomide—melanoma	0.000569	0.00427	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Vemurafenib—melanoma	0.000562	0.00423	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Dactinomycin—melanoma	0.000562	0.00422	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Temozolomide—melanoma	0.000559	0.0042	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Temozolomide—melanoma	0.000554	0.00416	CcSEcCtD
Ethinyl Estradiol—Alopecia—Bleomycin—melanoma	0.000536	0.00403	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Dactinomycin—melanoma	0.000535	0.00402	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Temozolomide—melanoma	0.000535	0.00402	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Carmustine—melanoma	0.000532	0.004	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Carmustine—melanoma	0.00053	0.00398	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Carmustine—melanoma	0.000527	0.00396	CcSEcCtD
Ethinyl Estradiol—Hot flush—Docetaxel—melanoma	0.000526	0.00395	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Vemurafenib—melanoma	0.000524	0.00394	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Docetaxel—melanoma	0.000521	0.00392	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Carmustine—melanoma	0.00052	0.00391	CcSEcCtD
Ethinyl Estradiol—Visual disturbance—Docetaxel—melanoma	0.000519	0.0039	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Temozolomide—melanoma	0.000514	0.00387	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Temozolomide—melanoma	0.000512	0.00385	CcSEcCtD
Ethinyl Estradiol—Asthenia—Vemurafenib—melanoma	0.000511	0.00384	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Carmustine—melanoma	0.00051	0.00384	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Temozolomide—melanoma	0.000509	0.00383	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Temozolomide—melanoma	0.000508	0.00382	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Temozolomide—melanoma	0.000505	0.0038	CcSEcCtD
Ethinyl Estradiol—Pruritus—Vemurafenib—melanoma	0.000503	0.00378	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Temozolomide—melanoma	0.000503	0.00378	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Temozolomide—melanoma	0.000502	0.00377	CcSEcCtD
Ethinyl Estradiol—Alopecia—Dactinomycin—melanoma	0.0005	0.00376	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Carmustine—melanoma	0.000495	0.00372	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Temozolomide—melanoma	0.000493	0.00371	CcSEcCtD
Ethinyl Estradiol—Estrone—CYP1B1—melanoma	0.000492	0.0873	CrCbGaD
Ethinyl Estradiol—Pain in extremity—Docetaxel—melanoma	0.000492	0.0037	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Bleomycin—melanoma	0.00049	0.00368	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Vemurafenib—melanoma	0.000487	0.00366	CcSEcCtD
Ethinyl Estradiol—Migraine—Docetaxel—melanoma	0.000484	0.00364	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Temozolomide—melanoma	0.000484	0.00364	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Temozolomide—melanoma	0.000478	0.00359	CcSEcCtD
Ethinyl Estradiol—Malaise—Bleomycin—melanoma	0.000476	0.00358	CcSEcCtD
Ethinyl Estradiol—Dizziness—Vemurafenib—melanoma	0.000471	0.00354	CcSEcCtD
Ethinyl Estradiol—Alopecia—Carmustine—melanoma	0.000468	0.00352	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Temozolomide—melanoma	0.000464	0.00349	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Carmustine—melanoma	0.000464	0.00349	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Temozolomide—melanoma	0.000462	0.00347	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Carmustine—melanoma	0.000461	0.00346	CcSEcCtD
Ethinyl Estradiol—Cough—Bleomycin—melanoma	0.000461	0.00346	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Dactinomycin—melanoma	0.000457	0.00343	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vemurafenib—melanoma	0.000452	0.0034	CcSEcCtD
Ethinyl Estradiol—Alopecia—Temozolomide—melanoma	0.000452	0.0034	CcSEcCtD
Ethinyl Estradiol—Rash—Vemurafenib—melanoma	0.000449	0.00337	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Temozolomide—melanoma	0.000448	0.00337	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Vemurafenib—melanoma	0.000448	0.00337	CcSEcCtD
Ethinyl Estradiol—Back pain—Carmustine—melanoma	0.000446	0.00335	CcSEcCtD
Ethinyl Estradiol—Headache—Vemurafenib—melanoma	0.000446	0.00335	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Temozolomide—melanoma	0.000446	0.00335	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Docetaxel—melanoma	0.000445	0.00334	CcSEcCtD
Ethinyl Estradiol—Discomfort—Bleomycin—melanoma	0.000444	0.00334	CcSEcCtD
Ethinyl Estradiol—Malaise—Dactinomycin—melanoma	0.000444	0.00334	CcSEcCtD
Ethinyl Estradiol—Oedema—Bleomycin—melanoma	0.000431	0.00324	CcSEcCtD
Ethinyl Estradiol—Back pain—Temozolomide—melanoma	0.000431	0.00324	CcSEcCtD
Ethinyl Estradiol—Infection—Bleomycin—melanoma	0.000428	0.00322	CcSEcCtD
Ethinyl Estradiol—Nausea—Vemurafenib—melanoma	0.000423	0.00318	CcSEcCtD
Ethinyl Estradiol—Discomfort—Dactinomycin—melanoma	0.000414	0.00311	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Temozolomide—melanoma	0.000413	0.00311	CcSEcCtD
Ethinyl Estradiol—Angioedema—Temozolomide—melanoma	0.000407	0.00306	CcSEcCtD
Ethinyl Estradiol—Oedema—Dactinomycin—melanoma	0.000402	0.00302	CcSEcCtD
Ethinyl Estradiol—Malaise—Temozolomide—melanoma	0.000402	0.00302	CcSEcCtD
Ethinyl Estradiol—Infection—Dactinomycin—melanoma	0.000399	0.003	CcSEcCtD
Ethinyl Estradiol—Anxiety—Carmustine—melanoma	0.000391	0.00294	CcSEcCtD
Ethinyl Estradiol—Cough—Temozolomide—melanoma	0.000389	0.00292	CcSEcCtD
Ethinyl Estradiol—Weight increased—Docetaxel—melanoma	0.000387	0.00291	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Docetaxel—melanoma	0.000385	0.00289	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Docetaxel—melanoma	0.000379	0.00285	CcSEcCtD
Ethinyl Estradiol—Infestation—Docetaxel—melanoma	0.000379	0.00285	CcSEcCtD
Ethinyl Estradiol—Anxiety—Temozolomide—melanoma	0.000378	0.00284	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000377	0.00283	CcSEcCtD
Ethinyl Estradiol—Oedema—Carmustine—melanoma	0.000376	0.00283	CcSEcCtD
Ethinyl Estradiol—Discomfort—Temozolomide—melanoma	0.000375	0.00282	CcSEcCtD
Ethinyl Estradiol—Infection—Carmustine—melanoma	0.000374	0.00281	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Docetaxel—melanoma	0.000374	0.00281	CcSEcCtD
Ethinyl Estradiol—Estradiol—CYP1B1—melanoma	0.000373	0.0661	CrCbGaD
Ethinyl Estradiol—Neuropathy peripheral—Docetaxel—melanoma	0.000372	0.00279	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Docetaxel—melanoma	0.000372	0.00279	CcSEcCtD
Ethinyl Estradiol—Oedema—Temozolomide—melanoma	0.000364	0.00273	CcSEcCtD
Ethinyl Estradiol—Infection—Temozolomide—melanoma	0.000361	0.00271	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Temozolomide—melanoma	0.000357	0.00268	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Bleomycin—melanoma	0.000355	0.00267	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Temozolomide—melanoma	0.000353	0.00265	CcSEcCtD
Ethinyl Estradiol—Fatigue—Dactinomycin—melanoma	0.000347	0.0026	CcSEcCtD
Ethinyl Estradiol—Urticaria—Bleomycin—melanoma	0.000342	0.00257	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Docetaxel—melanoma	0.000342	0.00257	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Docetaxel—melanoma	0.000341	0.00256	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Bleomycin—melanoma	0.000341	0.00256	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Docetaxel—melanoma	0.00034	0.00256	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Docetaxel—melanoma	0.000339	0.00254	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Docetaxel—melanoma	0.000338	0.00254	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Docetaxel—melanoma	0.000336	0.00253	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Docetaxel—melanoma	0.000334	0.00251	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Docetaxel—melanoma	0.000334	0.00251	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Dactinomycin—melanoma	0.000331	0.00249	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Dactinomycin—melanoma	0.000329	0.00247	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Docetaxel—melanoma	0.000328	0.00246	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Carmustine—melanoma	0.000325	0.00244	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Docetaxel—melanoma	0.000322	0.00242	CcSEcCtD
Ethinyl Estradiol—Constipation—Carmustine—melanoma	0.000322	0.00242	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Docetaxel—melanoma	0.000318	0.00239	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dactinomycin—melanoma	0.000318	0.00239	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Dactinomycin—melanoma	0.000318	0.00239	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Bleomycin—melanoma	0.000318	0.00239	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Temozolomide—melanoma	0.000314	0.00236	CcSEcCtD
Ethinyl Estradiol—Fatigue—Temozolomide—melanoma	0.000314	0.00236	CcSEcCtD
Ethinyl Estradiol—Constipation—Temozolomide—melanoma	0.000311	0.00234	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Carmustine—melanoma	0.00031	0.00233	CcSEcCtD
Ethinyl Estradiol—Asthenia—Bleomycin—melanoma	0.000309	0.00232	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Docetaxel—melanoma	0.000309	0.00232	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Carmustine—melanoma	0.000308	0.00231	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Docetaxel—melanoma	0.000307	0.00231	CcSEcCtD
Ethinyl Estradiol—Pruritus—Bleomycin—melanoma	0.000305	0.00229	CcSEcCtD
Ethinyl Estradiol—Alopecia—Docetaxel—melanoma	0.000301	0.00226	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Temozolomide—melanoma	0.0003	0.00225	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Docetaxel—melanoma	0.000298	0.00224	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Carmustine—melanoma	0.000297	0.00224	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Carmustine—melanoma	0.000297	0.00224	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Temozolomide—melanoma	0.000297	0.00223	CcSEcCtD
Ethinyl Estradiol—Estriol—ABCB1—melanoma	0.000297	0.0526	CrCbGaD
Ethinyl Estradiol—Malnutrition—Docetaxel—melanoma	0.000296	0.00223	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Dactinomycin—melanoma	0.000296	0.00223	CcSEcCtD
Ethinyl Estradiol—Urticaria—Temozolomide—melanoma	0.000289	0.00217	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dactinomycin—melanoma	0.000288	0.00217	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Temozolomide—melanoma	0.000287	0.00216	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Temozolomide—melanoma	0.000287	0.00216	CcSEcCtD
Ethinyl Estradiol—Back pain—Docetaxel—melanoma	0.000287	0.00215	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Docetaxel—melanoma	0.000285	0.00214	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Carmustine—melanoma	0.000277	0.00208	CcSEcCtD
Ethinyl Estradiol—Estramustine—ABCB1—melanoma	0.000276	0.0489	CrCbGaD
Ethinyl Estradiol—Diarrhoea—Dactinomycin—melanoma	0.000275	0.00207	CcSEcCtD
Ethinyl Estradiol—Vomiting—Bleomycin—melanoma	0.000274	0.00206	CcSEcCtD
Ethinyl Estradiol—Rash—Bleomycin—melanoma	0.000272	0.00204	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Bleomycin—melanoma	0.000272	0.00204	CcSEcCtD
Ethinyl Estradiol—Asthenia—Carmustine—melanoma	0.00027	0.00203	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Temozolomide—melanoma	0.000268	0.00201	CcSEcCtD
Ethinyl Estradiol—Asthenia—Temozolomide—melanoma	0.000261	0.00196	CcSEcCtD
Ethinyl Estradiol—Cough—Docetaxel—melanoma	0.000259	0.00194	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Carmustine—melanoma	0.000257	0.00193	CcSEcCtD
Ethinyl Estradiol—Pruritus—Temozolomide—melanoma	0.000257	0.00193	CcSEcCtD
Ethinyl Estradiol—Nausea—Bleomycin—melanoma	0.000256	0.00192	CcSEcCtD
Ethinyl Estradiol—Vomiting—Dactinomycin—melanoma	0.000256	0.00192	CcSEcCtD
Ethinyl Estradiol—Rash—Dactinomycin—melanoma	0.000254	0.0019	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000251	0.00188	CcSEcCtD
Ethinyl Estradiol—Dizziness—Carmustine—melanoma	0.000249	0.00187	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Temozolomide—melanoma	0.000249	0.00187	CcSEcCtD
Ethinyl Estradiol—Oedema—Docetaxel—melanoma	0.000242	0.00182	CcSEcCtD
Ethinyl Estradiol—Dizziness—Temozolomide—melanoma	0.00024	0.00181	CcSEcCtD
Ethinyl Estradiol—Infection—Docetaxel—melanoma	0.00024	0.00181	CcSEcCtD
Ethinyl Estradiol—Vomiting—Carmustine—melanoma	0.000239	0.0018	CcSEcCtD
Ethinyl Estradiol—Nausea—Dactinomycin—melanoma	0.000239	0.00179	CcSEcCtD
Ethinyl Estradiol—Estropipate—ALB—melanoma	0.000238	0.0422	CrCbGaD
Ethinyl Estradiol—Rash—Carmustine—melanoma	0.000237	0.00178	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Docetaxel—melanoma	0.000237	0.00178	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Carmustine—melanoma	0.000237	0.00178	CcSEcCtD
Ethinyl Estradiol—Headache—Carmustine—melanoma	0.000236	0.00177	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Docetaxel—melanoma	0.000235	0.00176	CcSEcCtD
Ethinyl Estradiol—Vomiting—Temozolomide—melanoma	0.000231	0.00174	CcSEcCtD
Ethinyl Estradiol—Rash—Temozolomide—melanoma	0.000229	0.00172	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Temozolomide—melanoma	0.000229	0.00172	CcSEcCtD
Ethinyl Estradiol—Headache—Temozolomide—melanoma	0.000228	0.00171	CcSEcCtD
Ethinyl Estradiol—Nausea—Carmustine—melanoma	0.000224	0.00168	CcSEcCtD
Ethinyl Estradiol—Nausea—Temozolomide—melanoma	0.000216	0.00162	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Docetaxel—melanoma	0.000209	0.00157	CcSEcCtD
Ethinyl Estradiol—Fatigue—Docetaxel—melanoma	0.000208	0.00157	CcSEcCtD
Ethinyl Estradiol—Constipation—Docetaxel—melanoma	0.000207	0.00155	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Docetaxel—melanoma	0.000199	0.0015	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Docetaxel—melanoma	0.000198	0.00149	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Docetaxel—melanoma	0.000191	0.00144	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Docetaxel—melanoma	0.000191	0.00144	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Docetaxel—melanoma	0.000178	0.00134	CcSEcCtD
Ethinyl Estradiol—Asthenia—Docetaxel—melanoma	0.000174	0.0013	CcSEcCtD
Ethinyl Estradiol—Pruritus—Docetaxel—melanoma	0.000171	0.00129	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Docetaxel—melanoma	0.000165	0.00124	CcSEcCtD
Ethinyl Estradiol—Norethindrone—ALB—melanoma	0.000163	0.029	CrCbGaD
Ethinyl Estradiol—Dizziness—Docetaxel—melanoma	0.00016	0.0012	CcSEcCtD
Ethinyl Estradiol—Norethindrone—ABCB1—melanoma	0.000156	0.0276	CrCbGaD
Ethinyl Estradiol—Methyltestosterone—ALB—melanoma	0.000155	0.0275	CrCbGaD
Ethinyl Estradiol—Vomiting—Docetaxel—melanoma	0.000154	0.00116	CcSEcCtD
Ethinyl Estradiol—Rash—Docetaxel—melanoma	0.000152	0.00115	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Docetaxel—melanoma	0.000152	0.00114	CcSEcCtD
Ethinyl Estradiol—Headache—Docetaxel—melanoma	0.000151	0.00114	CcSEcCtD
Ethinyl Estradiol—Estrone—ALB—melanoma	0.000148	0.0262	CrCbGaD
Ethinyl Estradiol—Nausea—Docetaxel—melanoma	0.000144	0.00108	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—ABCB1—melanoma	0.000142	0.0251	CrCbGaD
Ethinyl Estradiol—Estrone—ABCB1—melanoma	0.000141	0.025	CrCbGaD
Ethinyl Estradiol—Estradiol—ALB—melanoma	0.000112	0.0199	CrCbGaD
Ethinyl Estradiol—Estradiol—ABCB1—melanoma	0.000107	0.019	CrCbGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CB—melanoma	2e-05	0.000165	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTGS2—melanoma	1.99e-05	0.000164	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CD—melanoma	1.98e-05	0.000163	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PLA2G6—melanoma	1.97e-05	0.000163	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PRKCA—melanoma	1.97e-05	0.000162	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.97e-05	0.000162	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GPAM—melanoma	1.96e-05	0.000162	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.96e-05	0.000162	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.95e-05	0.000161	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ERCC2—melanoma	1.95e-05	0.000161	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ALB—melanoma	1.95e-05	0.000161	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CDKN1B—melanoma	1.93e-05	0.000159	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—CDKN2B—melanoma	1.9e-05	0.000157	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PHGDH—melanoma	1.9e-05	0.000157	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—LUM—melanoma	1.9e-05	0.000157	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HS3ST5—melanoma	1.9e-05	0.000156	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HPSE—melanoma	1.86e-05	0.000154	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—VDR—melanoma	1.85e-05	0.000153	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CUBN—melanoma	1.83e-05	0.000151	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CTNNB1—melanoma	1.82e-05	0.000151	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—F2R—melanoma	1.8e-05	0.000148	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CDKN1A—melanoma	1.78e-05	0.000147	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTEN—melanoma	1.78e-05	0.000147	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—VCAN—melanoma	1.77e-05	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.77e-05	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SDHD—melanoma	1.77e-05	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CSPG4—melanoma	1.77e-05	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—BSG—melanoma	1.77e-05	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EDNRB—melanoma	1.74e-05	0.000144	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTEN—melanoma	1.73e-05	0.000143	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CB—melanoma	1.72e-05	0.000142	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GPAM—melanoma	1.71e-05	0.000141	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PRKCA—melanoma	1.71e-05	0.000141	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTGS2—melanoma	1.71e-05	0.000141	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—ERCC2—melanoma	1.7e-05	0.00014	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PTK2B—melanoma	1.69e-05	0.00014	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.68e-05	0.000138	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PLA2G6—melanoma	1.67e-05	0.000138	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GAB2—melanoma	1.65e-05	0.000136	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GNA11—melanoma	1.65e-05	0.000136	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FLT1—melanoma	1.64e-05	0.000135	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.63e-05	0.000134	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.62e-05	0.000133	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.59e-05	0.000132	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.59e-05	0.000132	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—STAT3—melanoma	1.59e-05	0.000131	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NRAS—melanoma	1.59e-05	0.000131	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCR4—melanoma	1.55e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FOXO4—melanoma	1.55e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HDAC2—melanoma	1.55e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CG—melanoma	1.54e-05	0.000127	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—melanoma	1.53e-05	0.000126	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GNAQ—melanoma	1.53e-05	0.000126	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MAPK3—melanoma	1.52e-05	0.000125	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.52e-05	0.000125	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.51e-05	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MAPK3—melanoma	1.5e-05	0.000124	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—VCAN—melanoma	1.5e-05	0.000124	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP17A1—melanoma	1.5e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTEN—melanoma	1.49e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPARG—melanoma	1.49e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—melanoma	1.48e-05	0.000122	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—melanoma	1.46e-05	0.000121	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PLA2G6—melanoma	1.46e-05	0.00012	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MAPK1—melanoma	1.45e-05	0.000119	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EGFR—melanoma	1.45e-05	0.000119	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—AKT1—melanoma	1.44e-05	0.000119	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SYK—melanoma	1.44e-05	0.000119	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PLCB4—melanoma	1.44e-05	0.000118	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.42e-05	0.000117	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NGFR—melanoma	1.41e-05	0.000116	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AKT3—melanoma	1.41e-05	0.000116	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ITGAV—melanoma	1.41e-05	0.000116	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GNA11—melanoma	1.41e-05	0.000116	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.38e-05	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—FASN—melanoma	1.38e-05	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.37e-05	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—NOTCH1—melanoma	1.37e-05	0.000113	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KRAS—melanoma	1.37e-05	0.000113	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—SLC5A5—melanoma	1.36e-05	0.000112	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CD—melanoma	1.36e-05	0.000112	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC6A11—melanoma	1.35e-05	0.000111	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIP4K2A—melanoma	1.35e-05	0.000111	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.34e-05	0.00011	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ALB—melanoma	1.34e-05	0.00011	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—MTAP—melanoma	1.31e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GNAQ—melanoma	1.31e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CD44—melanoma	1.31e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SOCS1—melanoma	1.31e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—VCAN—melanoma	1.31e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—S100B—melanoma	1.3e-05	0.000108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPARG—melanoma	1.29e-05	0.000107	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP17A1—melanoma	1.27e-05	0.000104	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP1B1—melanoma	1.26e-05	0.000104	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CA—melanoma	1.25e-05	0.000103	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.25e-05	0.000103	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ERBB4—melanoma	1.25e-05	0.000103	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN2B—melanoma	1.24e-05	0.000102	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.23e-05	0.000102	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CA—melanoma	1.22e-05	0.000101	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CD86—melanoma	1.2e-05	9.86e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GNA11—melanoma	1.2e-05	9.86e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EDN1—melanoma	1.19e-05	9.79e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CB—melanoma	1.18e-05	9.74e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PHGDH—melanoma	1.17e-05	9.66e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—LUM—melanoma	1.17e-05	9.66e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTGS2—melanoma	1.17e-05	9.66e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—FASN—melanoma	1.17e-05	9.65e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HRAS—melanoma	1.16e-05	9.58e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CSF2—melanoma	1.16e-05	9.57e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FGF1—melanoma	1.16e-05	9.57e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SLC5A5—melanoma	1.15e-05	9.49e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HPSE—melanoma	1.15e-05	9.47e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—E2F1—melanoma	1.13e-05	9.36e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.13e-05	9.33e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CUBN—melanoma	1.13e-05	9.3e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PDGFRA—melanoma	1.12e-05	9.26e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ITGB3—melanoma	1.11e-05	9.17e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PRKCA—melanoma	1.11e-05	9.17e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CD44—melanoma	1.11e-05	9.17e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GNAQ—melanoma	1.11e-05	9.17e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—IL6—melanoma	1.11e-05	9.16e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP17A1—melanoma	1.1e-05	9.1e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SPP1—melanoma	1.09e-05	8.99e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SDHD—melanoma	1.09e-05	8.98e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CSPG4—melanoma	1.09e-05	8.98e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—BSG—melanoma	1.09e-05	8.98e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.09e-05	8.98e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAP2K2—melanoma	1.09e-05	8.96e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.08e-05	8.89e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP1B1—melanoma	1.07e-05	8.79e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GPAM—melanoma	1.05e-05	8.7e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CA—melanoma	1.05e-05	8.67e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GNA11—melanoma	1.04e-05	8.59e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ABCB1—melanoma	1.04e-05	8.55e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TERT—melanoma	1.03e-05	8.53e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—RAC1—melanoma	1.03e-05	8.5e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—AKT1—melanoma	1.02e-05	8.45e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.02e-05	8.42e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTEN—melanoma	1.02e-05	8.42e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—FASN—melanoma	1.02e-05	8.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—AKT1—melanoma	1.01e-05	8.36e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SLC5A5—melanoma	1e-05	8.27e-05	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—AKT1—melanoma	9.98e-06	8.23e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HIF1A—melanoma	9.88e-06	8.15e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GNAQ—melanoma	9.68e-06	7.99e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CD44—melanoma	9.68e-06	7.99e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PRKCA—melanoma	9.54e-06	7.87e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ERCC2—melanoma	9.46e-06	7.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KDR—melanoma	9.45e-06	7.8e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.4e-06	7.76e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP1B1—melanoma	9.28e-06	7.66e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FN1—melanoma	9.1e-06	7.51e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PLA2G6—melanoma	8.97e-06	7.39e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NOTCH1—melanoma	8.9e-06	7.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ABCB1—melanoma	8.77e-06	7.24e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CD80—melanoma	8.72e-06	7.2e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APC—melanoma	8.71e-06	7.18e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CG—melanoma	8.71e-06	7.18e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KIT—melanoma	8.71e-06	7.18e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EGF—melanoma	8.61e-06	7.1e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—AKT1—melanoma	8.58e-06	7.08e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—BRAF—melanoma	8.19e-06	6.75e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PRKCA—melanoma	8.07e-06	6.66e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—VCAN—melanoma	8.05e-06	6.64e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ERCC2—melanoma	8.01e-06	6.61e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF1—melanoma	7.97e-06	6.58e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAP2K1—melanoma	7.71e-06	6.36e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CD—melanoma	7.66e-06	6.31e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MAPK3—melanoma	7.58e-06	6.25e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CG—melanoma	7.47e-06	6.16e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—melanoma	7.37e-06	6.08e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FGF2—melanoma	7.33e-06	6.05e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPARG—melanoma	7.21e-06	5.95e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CA—melanoma	7.2e-06	5.94e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PRKCA—melanoma	7.03e-06	5.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ERCC2—melanoma	6.98e-06	5.75e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MDM2—melanoma	6.86e-06	5.66e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP17A1—melanoma	6.79e-06	5.6e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ERBB2—melanoma	6.76e-06	5.58e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CB—melanoma	6.67e-06	5.5e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.63e-06	5.47e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CD—melanoma	6.57e-06	5.42e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALB—melanoma	6.48e-06	5.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GNA11—melanoma	6.42e-06	5.29e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL8—melanoma	6.41e-06	5.29e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CG—melanoma	6.32e-06	5.22e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—FASN—melanoma	6.28e-06	5.18e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN1B—melanoma	6.26e-06	5.17e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC5A5—melanoma	6.18e-06	5.09e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CASP3—melanoma	6.14e-06	5.06e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL2—melanoma	6.13e-06	5.05e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPARG—melanoma	6.1e-06	5.04e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCND1—melanoma	5.97e-06	4.93e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GNAQ—melanoma	5.97e-06	4.92e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CD44—melanoma	5.97e-06	4.92e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CTNNB1—melanoma	5.92e-06	4.88e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—AKT1—melanoma	5.88e-06	4.85e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP9—melanoma	5.8e-06	4.78e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN1A—melanoma	5.78e-06	4.77e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PTEN—melanoma	5.77e-06	4.76e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NFKB1—melanoma	5.74e-06	4.73e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CB—melanoma	5.72e-06	4.72e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP1B1—melanoma	5.72e-06	4.72e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTGS2—melanoma	5.67e-06	4.68e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CD—melanoma	5.56e-06	4.59e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CG—melanoma	5.51e-06	4.55e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALB—melanoma	5.49e-06	4.53e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPARG—melanoma	5.32e-06	4.39e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFA—melanoma	5.21e-06	4.3e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—STAT3—melanoma	5.16e-06	4.25e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NRAS—melanoma	5.14e-06	4.24e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—AKT1—melanoma	5.11e-06	4.22e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTEN—melanoma	4.95e-06	4.08e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK3—melanoma	4.93e-06	4.06e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CB—melanoma	4.85e-06	4e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CD—melanoma	4.84e-06	4e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTGS2—melanoma	4.8e-06	3.96e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—melanoma	4.79e-06	3.95e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALB—melanoma	4.78e-06	3.94e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCB1—melanoma	4.71e-06	3.88e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK1—melanoma	4.69e-06	3.87e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EGFR—melanoma	4.69e-06	3.87e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KRAS—melanoma	4.43e-06	3.65e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PRKCA—melanoma	4.33e-06	3.58e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ERCC2—melanoma	4.3e-06	3.55e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CB—melanoma	4.22e-06	3.48e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTEN—melanoma	4.19e-06	3.45e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTGS2—melanoma	4.18e-06	3.45e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CA—melanoma	4.07e-06	3.36e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—melanoma	3.94e-06	3.25e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HRAS—melanoma	3.76e-06	3.1e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTEN—melanoma	3.65e-06	3.01e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL6—melanoma	3.6e-06	2.97e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CA—melanoma	3.49e-06	2.88e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CG—melanoma	3.39e-06	2.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AKT1—melanoma	3.32e-06	2.74e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPARG—melanoma	3.28e-06	2.7e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CD—melanoma	2.98e-06	2.46e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CA—melanoma	2.95e-06	2.44e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALB—melanoma	2.95e-06	2.43e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—AKT1—melanoma	2.85e-06	2.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CB—melanoma	2.6e-06	2.15e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTGS2—melanoma	2.58e-06	2.13e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CA—melanoma	2.57e-06	2.12e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—AKT1—melanoma	2.41e-06	1.99e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTEN—melanoma	2.25e-06	1.85e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—AKT1—melanoma	2.1e-06	1.73e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CA—melanoma	1.59e-06	1.31e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—AKT1—melanoma	1.3e-06	1.07e-05	CbGpPWpGaD
